Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
about
Clinical applications of mouse models for breast cancer engaging HER2/neu.Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signalingTargeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapyAntibody therapeutics for treating prostate cancer: where are we now and what comes next?CD90 positive cells exhibit aggressive radioresistance in esophageal squamous cell carcinomaEffects of Cetuximab and Erlotinib on the behaviour of cancer stem cells in head and neck squamous cell carcinoma.
P2860
Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Targeting cancer stem cell-spe ...... coming cancer drug resistance.
@en
type
label
Targeting cancer stem cell-spe ...... coming cancer drug resistance.
@en
prefLabel
Targeting cancer stem cell-spe ...... coming cancer drug resistance.
@en
P2093
P2860
P1433
P1476
Targeting cancer stem cell-spe ...... coming cancer drug resistance.
@en
P2093
Ali Mohammad Alizadeh
Peyman Ranji
Sara Saeedikhoo
Tayyebali Salmani Kesejini
P2860
P2888
P304
13059-13075
P356
10.1007/S13277-016-5294-5
P577
2016-08-26T00:00:00Z
P6179
1017761745